So, everyone's going to get Libre on prescription on 1st November?!

In short, they're not. Nobody has them on prescription yet (edit 03/11/17 - almost nobody - there is some evidence that a few people might have them, but yet to be totally convinced). There are a small number that have persuaded their doctor/specialist to fund, but it's difficult to know exact circumstances and it hasn't been done in a coherent way.

The situation became different from 1st November, in that it is now possible to prescribe the Libre. However, the budgets are controlled by the local health authority (CCG) and ultimately they decide whether to fund or not and who to fund it for. There could be a chance that a GP/Specialist could go 'maverick' and prescribe without authority...but like current funding, will be rare and not coherently managed.

The problem the CCG have is two-fold. Firstly, budgets run from April to April. Starting funding in November means that they'll have to find extra cash from somewhere to fund the Libre - at least initially, it is going to cost more.

Secondly, and perhaps more importantly, there's not guidance from NICE about who should receive the Libre on prescription. There is limited health economic data and only a few large-scale trials. Cost-effectiveness is yet to be proven any more than anecdotally.

As patients, our best bet for getting coherent funding of Libre is through patient groups like JDRF, Diabetes UK and Input. Rest assured they are working very hard to make Libre accessible to as many of the people that really need it as possible.

Speaking to doctors etc. may increase awareness, but as for funding across a wide area, the patient groups are the ones that are likely to make the biggest difference.

This information is gathered from my reading and speaking to interested parties, so if anyone has any other evidence or info, please share.

These two articles help:
http://www.inputdiabetes.org.uk/cgm/libre/ and http://www.inputdiabetes.org.uk/2017/10/access-flash/

Comments

PhilT said…

The case for NHS funding isn't black & white. Current user experiences are dominated by self selecting motivated users willing to fund themselves. The experiences of users on "free trials" or where NHS clinics apply the sensor to patients seem less clear cut.

The people with worst BG control are probably in denial or in some way impaired from getting on top of it, the Libre can give extra data but that doesn't help the data challenged.

3 November 2017 at 08:09

NickC said…

Thanks Phil.

3 November 2017 at 08:45

The CCG Project!

In order to find out the situation around the country for Libre prescribing now that the national policy has been published, I have made the decision to contact many of them to find out their plans. I have arbitrarily chosen to contact all English CCGs that in December 2018 prescribed Libre via Primary Care to less than 5% of their population (and one specific request from a group member). I had hoped this would be a small list, but there are 135 CCGs on the list. I may have bitten off more than I can chew, but I'm committed to doing this and feeding back. It worked before and hopefully this level of scrutiny will bring similar results. Below is a screenshot of the base document I am sending to each of the CCGs - it has some fields that are merge fields, so don't worry about the brackets and codes in the document (I found a typo, which has now been corrected too) . The major piece of work with respect to this is finding the right person to contact. However, I have s

Abbott dX 2022 Barcelona - "Make it Count"

For the past four years I've been invited by Abbott to a conference bringing together people with diabetes from across Europe to discuss various topics. The first year I was meant to attend, it was my 'man v horse' year (the horse won!), so was unable to attend and then the pandemic hit so two further dX's were held virtually. I was fortunate to be asked to present at last year's session. This year's event was back in-person and held in Barcelona, coinciding with the latter part of the ATTD conference. At this point, I must make it very clear - Abbott invited me to the 2022 European Diabetes Exchange forum (dX), that took place in Barcelona. I attended this two-day event to connect and interact with inspirational and influential people in the diabetes community. Abbott paid for my ticket and accommodation. #InvitedbyAbbott. This is formal and it needs to be - I have not been required to do anything by Abbott as a result of my attendance and I hope that m

Finally an Update!

So, I have finally got the motivation to update my blog. There's probably nobody reading it anymore, but just in case...here goes. What has been happening? Well, I am still honeymooning in terms of my diabetes, so need less insulin than previously. It is proving a bit difficult to judge and I had a bad hypo last week. Basically, I was almost unconscious and Claire had gone out for the evening! Luckily I found some wine gums and came out of it eventually. Last weekend was Josh's thanksgiving. Our church doesn't really approve of christenings of babies whose parents are not both confirmed. As neither of us are, then a thanksgiving was the choice. It turned out to be a lovely service and the small group of people that we had meant that it was a great day. The sun even shone for most of it. This weekend is the Open Day at work. I have helped organise it, including getting a person to create a special newspaper for the day and be there to add pictures and make a live n

T1 Tenor

Search This Blog